BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jansen KU, Anderson AS. The role of vaccines in fighting antimicrobial resistance (AMR). Hum Vaccin Immunother 2018;14:2142-9. [PMID: 29787323 DOI: 10.1080/21645515.2018.1476814] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Jungbluth S, Depraetere H, Slezak M, Christensen D, Stockhofe N, Beloeil L. A gaps-and-needs analysis of vaccine R&D in Europe: Recommendations to improve the research infrastructure. Biologicals 2022. [DOI: 10.1016/j.biologicals.2022.02.003] [Reference Citation Analysis]
2 Kumar S. Reduction in antimicrobial resistance by the way of extensive vaccination. Hum Vaccin Immunother 2018;14:2955-6. [PMID: 30060701 DOI: 10.1080/21645515.2018.1506679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Wasserman M, Chapman R, Lapidot R, Sutton K, Dillon-Murphy D, Patel S, Chilson E, Snow V, Farkouh R, Pelton S. Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children. Emerg Infect Dis 2021;27:1627-36. [PMID: 34013855 DOI: 10.3201/eid2706.204238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Smith PW, Agbaje M, LeRoux-Pullen L, Van Dyk D, Debusho LK, Shittu A, Sirdar MM, Fasanmi OG, Adebowale O, Fasina FO. Implication of the knowledge and perceptions of veterinary students of antimicrobial resistance for future prescription of antimicrobials in animal health, South Africa. J S Afr Vet Assoc 2019;90:e1-8. [PMID: 31714110 DOI: 10.4102/jsava.v90i0.1765] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
5 Vlaeminck J, Raafat D, Surmann K, Timbermont L, Normann N, Sellman B, van Wamel WJB, Malhotra-Kumar S. Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia. Toxins (Basel) 2020;12:E721. [PMID: 33218049 DOI: 10.3390/toxins12110721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Godman B, Egwuenu A, Haque M, Malande OO, Schellack N, Kumar S, Saleem Z, Sneddon J, Hoxha I, Islam S, Mwita J, do Nascimento RCRM, Dias Godói IP, Niba LL, Amu AA, Acolatse J, Incoom R, Sefah IA, Opanga S, Kurdi A, Chikowe I, Khuluza F, Kibuule D, Ogunleye OO, Olalekan A, Markovic-Pekovic V, Meyer JC, Alfadl A, Phuong TNT, Kalungia AC, Campbell S, Pisana A, Wale J, Seaton RA. Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries. Life (Basel) 2021;11:528. [PMID: 34200116 DOI: 10.3390/life11060528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jamshidi MP, Cairns C, Chong S, St Michael F, Vinogradov EV, Cox AD, Sauvageau J. Synthesis and Immunogenicity of a Methyl Rhamnan Pentasaccharide Conjugate from Pseudomonas aeruginosa A-Band Polysaccharide. ACS Infect Dis 2022;8:1347-55. [PMID: 35674342 DOI: 10.1021/acsinfecdis.2c00184] [Reference Citation Analysis]
8 Chevalier-Cottin EP, Ashbaugh H, Brooke N, Gavazzi G, Santillana M, Burlet N, Tin Tin Htar M. Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases. Infect Dis Ther 2020;9:467-80. [PMID: 32583334 DOI: 10.1007/s40121-020-00312-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Damas MSF, Mazur FG, Freire CCM, da Cunha AF, Pranchevicius MDS. A Systematic Immuno-Informatic Approach to Design a Multiepitope-Based Vaccine Against Emerging Multiple Drug Resistant Serratia marcescens. Front Immunol 2022;13:768569. [PMID: 35371033 DOI: 10.3389/fimmu.2022.768569] [Reference Citation Analysis]
10 Wright K, Plain K, Purdie A, Saunders BM, de Silva K. Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals. Infect Immun 2019;88:e00401-19. [PMID: 31527123 DOI: 10.1128/IAI.00401-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
11 Ismail S, Ahmad S, Azam SS. Vaccinomics to design a novel single chimeric subunit vaccine for broad-spectrum immunological applications targeting nosocomial Enterobacteriaceae pathogens. European Journal of Pharmaceutical Sciences 2020;146:105258. [DOI: 10.1016/j.ejps.2020.105258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Holm M, Zellweger RM, Poudyal N, Smith KH, Joh HS, Marks F. Measuring the Link Between Vaccines and Antimicrobial Resistance in Low Resource Settings – Limitations and Opportunities in Direct and Indirect Assessments and Implications for Impact Studies. Front Trop Dis 2022;3:805833. [DOI: 10.3389/fitd.2022.805833] [Reference Citation Analysis]
13 Ozawa S, Chen HH, Rao GG, Eguale T, Stringer A. Value of pneumococcal vaccination in controlling the development of antimicrobial resistance (AMR): Case study using DREAMR in Ethiopia. Vaccine 2021;39:6700-11. [PMID: 34538697 DOI: 10.1016/j.vaccine.2021.04.024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Navarro-Torné A, Curcio D, Moïsi JC, Jodar L. Burden of invasive group B Streptococcus disease in non-pregnant adults: A systematic review and meta-analysis. PLoS One 2021;16:e0258030. [PMID: 34591924 DOI: 10.1371/journal.pone.0258030] [Reference Citation Analysis]
15 Antonelli-Incalzi R, Blasi F, Conversano M, Gabutti G, Giuffrida S, Maggi S, Marano C, Rossi A, Vicentini M. Manifesto on the Value of Adult Immunization: "We Know, We Intend, We Advocate". Vaccines (Basel) 2021;9:1232. [PMID: 34835163 DOI: 10.3390/vaccines9111232] [Reference Citation Analysis]
16 Mann A, Nehra K, Rana JS, Dahiya T. Antibiotic resistance in agriculture: Perspectives on upcoming strategies to overcome upsurge in resistance. Curr Res Microb Sci 2021;2:100030. [PMID: 34841321 DOI: 10.1016/j.crmicr.2021.100030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Banerjee K, Motley MP, Diago-Navarro E, Fries BC. Serum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients. mSphere 2021;6:e01335-20. [PMID: 33658281 DOI: 10.1128/mSphere.01335-20] [Reference Citation Analysis]
18 Guerrini G, Magrì D, Gioria S, Medaglini D, Calzolai L. Characterization of nanoparticles-based vaccines for COVID-19. Nat Nanotechnol 2022;17:570-6. [PMID: 35710950 DOI: 10.1038/s41565-022-01129-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Gurney J, Brown SP, Kaltz O, Hochberg ME. Steering Phages to Combat Bacterial Pathogens. Trends Microbiol 2020;28:85-94. [PMID: 31744662 DOI: 10.1016/j.tim.2019.10.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
20 Aslowayeh N, Albutti A, Al-shouli ST. Reverse Vaccinology and Immunoinformatic Assisted Designing of a Multi-Epitopes Based Vaccine Against Nosocomial Burkholderia cepacia. Front Microbiol 2022;13:929400. [DOI: 10.3389/fmicb.2022.929400] [Reference Citation Analysis]
21 Hernando-Amado S, Coque TM, Baquero F, Martínez JL. Defining and combating antibiotic resistance from One Health and Global Health perspectives. Nat Microbiol 2019;4:1432-42. [PMID: 31439928 DOI: 10.1038/s41564-019-0503-9] [Cited by in Crossref: 143] [Cited by in F6Publishing: 136] [Article Influence: 47.7] [Reference Citation Analysis]
22 Du QQ, Shi W, Yu D, Yao KH. Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines. Hum Vaccin Immunother 2021;:1-10. [PMID: 34726580 DOI: 10.1080/21645515.2021.1985353] [Reference Citation Analysis]
23 Pérez de la Lastra JM, Anand U, González-Acosta S, López MR, Dey A, Bontempi E, Morales delaNuez A. Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides? Front Immunol 2022;13:921483. [PMID: 35720330 DOI: 10.3389/fimmu.2022.921483] [Reference Citation Analysis]
24 Hernando-Amado S, Coque TM, Baquero F, Martínez JL. Antibiotic Resistance: Moving From Individual Health Norms to Social Norms in One Health and Global Health. Front Microbiol 2020;11:1914. [PMID: 32983000 DOI: 10.3389/fmicb.2020.01914] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
25 Michel JP. The well-known and less well-known benefits of vaccines. Aging Clin Exp Res 2020;32:1401-4. [PMID: 32602068 DOI: 10.1007/s40520-020-01638-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Tian M, He X, Feng Y, Wang W, Chen H, Gong M, Liu D, Clarke JL, van Eerde A. Pollution by Antibiotics and Antimicrobial Resistance in LiveStock and Poultry Manure in China, and Countermeasures. Antibiotics (Basel) 2021;10:539. [PMID: 34066587 DOI: 10.3390/antibiotics10050539] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hulme J. Application of Nanomaterials in the Prevention, Detection, and Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA). Pharmaceutics 2022;14:805. [DOI: 10.3390/pharmaceutics14040805] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chorro L, Li Z, Chu L, Singh S, Gu J, Kim JH, Dutta K, Pan R, Kodali S, Ndreu D, Patel A, Hawkins JC, Ponce C, Silmon de Monerri N, Keeney D, Illenberger A, Jones CH, Andrew L, Lotvin J, Prasad AK, Kanevsky I, Jansen KU, Anderson AS, Donald RGK. Preclinical Immunogenicity and Efficacy of Optimized O25b O-Antigen Glycoconjugates To Prevent MDR ST131 E. coli Infections. Infect Immun 2022;:e0002222. [PMID: 35311580 DOI: 10.1128/iai.00022-22] [Reference Citation Analysis]
29 Sheppard CL, Groves N, Andrews N, Litt DJ, Fry NK, Southern J, Miller E. The Genomics of Streptococcus Pneumoniae Carriage Isolates from UK Children and Their Household Contacts, Pre-PCV7 to Post-PCV13. Genes (Basel) 2019;10:E687. [PMID: 31500179 DOI: 10.3390/genes10090687] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
30 Girgis MM, Abd El-Aziz AM, Hassan R, Ali YM. Immunization with proline rich region of pneumococcal surface protein A has no role in protection against Streptococcus pneumoniae serotype 19F. Microb Pathog 2020;138:103761. [PMID: 31560974 DOI: 10.1016/j.micpath.2019.103761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Champredon D, Shoukat A, Moghadas SM. Effectiveness and cost-effectiveness of a Clostridium difficile vaccine candidate in a hospital setting. Vaccine 2020;38:2585-91. [PMID: 32014268 DOI: 10.1016/j.vaccine.2020.01.073] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Petersen MR, Cosgrove SE, Quinn TC, Patel EU, Kate Grabowski M, Tobian AAR. Prescription Antibiotic Use Among the US population 1999-2018: National Health and Nutrition Examination Surveys. Open Forum Infect Dis 2021;8:ofab224. [PMID: 34295941 DOI: 10.1093/ofid/ofab224] [Reference Citation Analysis]
33 Bloom DE, Kirby PN, Pugh S, Stawasz A. Commentary: Why Has Uptake of Pneumococcal Vaccines for Children Been So Slow? The Perils of Undervaluation. Pediatric Infectious Disease Journal 2020;39:145-56. [DOI: 10.1097/inf.0000000000002521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
34 Bekeredjian-Ding I. Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections. Front Immunol 2020;11:1755. [PMID: 32849627 DOI: 10.3389/fimmu.2020.01755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Sharma A, Singh A, Dar MA, Kaur RJ, Charan J, Iskandar K, Haque M, Murti K, Ravichandiran V, Dhingra S. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility. J Infect Public Health 2021;15:172-81. [PMID: 34972026 DOI: 10.1016/j.jiph.2021.12.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Riu F, Ruda A, Ibba R, Sestito S, Lupinu I, Piras S, Widmalm G, Carta A. Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview. Pharmaceuticals 2022;15:942. [DOI: 10.3390/ph15080942] [Reference Citation Analysis]
37 Barie PS, Narayan M, Sawyer RG. Immunization Against Staphylococcus aureus Infections. Surg Infect (Larchmt) 2018;19:750-6. [PMID: 31033407 DOI: 10.1089/sur.2018.263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Majumder MAA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, Gittens-St Hilaire M. Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health. Infect Drug Resist 2020;13:4713-38. [PMID: 33402841 DOI: 10.2147/IDR.S290835] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
39 Avila-Agüero ML, Soriano-Fallas A, Brenes-Chacón H, Brea-Del Castillo J. Can vaccines act as a mechanism to reduce antimicrobial resistance? Expert Rev Vaccines 2020;19:595-8. [PMID: 32657176 DOI: 10.1080/14760584.2020.1791087] [Reference Citation Analysis]
40 Godman B, Egwuenu A, Wesangula E, Schellack N, Kalungia AC, Tiroyakgosi C, Kgatlwane J, Mwita JC, Patrick O, Niba LL, Amu AA, Oguntade RT, Alabi ME, Ncube NB, Sefah IA, Acolatse J, Incoom R, Guantai AN, Oluka M, Opanga S, Chikowe I, Khuluza F, Chiumia FK, Jana CE, Kalemeera F, Hango E, Fadare J, Ogunleye OO, Ebruke BE, Meyer JC, Massele A, Malande OO, Kibuule D, Kapona O, Zaranyika T, Bwakura-dangarembizi M, Kujinga T, Saleem Z, Kurdi A, Shahwan M, Jairoun AA, Wale J, Brink AJ. Tackling antimicrobial resistance across sub-Saharan Africa; current challenges and implications for the future. Expert Opinion on Drug Safety. [DOI: 10.1080/14740338.2022.2106368] [Reference Citation Analysis]
41 Morris C, Glennie SJ, Lam HS, Baum HE, Kandage D, Williams NA, Morgan DJ, Woolfson DN, Davidson AD. A Modular Vaccine Platform Combining Self-Assembled Peptide Cages and Immunogenic Peptides. Adv Funct Mater 2019;29:1807357. [PMID: 32313545 DOI: 10.1002/adfm.201807357] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
42 Moore HC, Cannon JW, Kaslow DC, Lamagni T, Bowen AC, Miller KM, Cherian T, Carapetis J, Van Beneden C; SAVAC Burden of Disease Working Group. A systematic framework for prioritising burden of disease data required for vaccine development and implementation: the case for group A streptococcal diseases. Clin Infect Dis 2022:ciac291. [PMID: 35438130 DOI: 10.1093/cid/ciac291] [Reference Citation Analysis]
43 El-Kattan N, Emam AN, Mansour AS, Ibrahim MA, Abd El-Razik AB, Allam KAM, Riad NY, Ibrahim SA. Curcumin assisted green synthesis of silver and zinc oxide nanostructures and their antibacterial activity against some clinical pathogenic multi-drug resistant bacteria. RSC Adv 2022;12:18022-38. [PMID: 35874032 DOI: 10.1039/d2ra00231k] [Reference Citation Analysis]
44 Zhu Z, Antenucci F, Villumsen KR, Bojesen AM. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance. mBio 2021;12:e0170721. [PMID: 34372691 DOI: 10.1128/mBio.01707-21] [Reference Citation Analysis]